Facts, Not Labels: The Limits of Delaware Notice Pleading
In Caerus Group, LLC v. Chemicar Europe NV, No. 2025-0393-BWD, 2026 WL 668208 (Del. Ch. Mar. 10, 2026), the Delaware Court of Chancery issued a strong reminder that notice pleading does not mean no pleading. Vice Chancellor David dismissed claims arising out of a failed automotive-products joint venture because the pleadings substituted conclusions and speculations for facts and therefore could not pass muster under Rule 12(b)(6). Chemicar underscores that the Court of Chancery will closely scrutinize the level of factual detail provided in determining whether a complaint is viable or merely a conclusory grievance, particularly where standards like entire fairness, gross negligence, or knowing participation are in play. As the court put it, quoting Harbor Finance Partners v. Huizenga, “[a]lthough Delaware has a notice pleading standard, that standard does not totally relieve a plaintiff of the burden to plead facts, not conclusions.” The decision offers a useful roadmap for challenging thinly pleaded or conclusory claims at the motion to dismiss stage, including where a complaint alleges an interested transaction that may trigger entire-fairness review; even then, “entire fairness is not . . . a free pass to trial.”
Background
Caerus Group, LLC (“Caerus”) and Chemicar Europe NV (“Chemicar”) formed Finixa USA, Inc. (“Finixa USA” or the “Company”) as a Delaware corporation and joint venture to import and distribute Chemicar-manufactured automotive refinishing products in the United States. The parties entered into a shareholders agreement governing the joint venture’s governance and information rights (the “Shareholders Agreement”). Chemicar held 60% of the equity and Caerus held 40%, but governance was balanced: the board of directors (the “Board”) was split evenly between two Chemicar designees and two Caerus designees, and key actions required the approval of at least one director from each side. Mitch Penney served as both a director and the Company’s CEO. Penney also entered into an employment agreement with Finixa USA governing his role as CEO (the “Employment Agreement”).
When the venture underperformed, Chemicar blamed Penney. Chemicar’s theory was that Penney used his operational control, with Caerus’s support, to keep Chemicar in the dark, pursue an unduly narrow sales strategy, and favor entities tied to Penney’s circle. The factual support for Chemicar’s allegations was sparse. Chemicar alleged “repeated requests” for reports and information, but it did not identify who made the requests, when they were made, what information was requested, or how Penney responded. It alleged that payments to UYL Color Supply, Inc. (“UYL”) —a third-party vendor in which Penney, or his family members, and another Caerus designee, allegedly had a financial interest—were “prioritized” over Chemicar’s invoices, but did not plead that Finixa USA lacked funds to pay all vendors. It alleged that UYL was “overpaid,” but did not plead the goods or services the third party provided, their value, or the amounts paid. Chemicar also alleged approval rights problems relating to UYL and National Coatings & Supplies, Inc., which acquired UYL in January 2024, but did not tie those assertions to facts showing that the challenged conduct fell within the contract provisions invoked.
Chemicar asserted four claims relevant to the motions: breach of fiduciary duty and breach of contract against Penney, and breach of the Shareholders Agreement and aiding and abetting against Caerus. Caerus and Penney both moved to dismiss for failure to state a claim under Rule 12(b)(6), and the court consolidated the actions.
The Decision
Vice Chancellor David granted both motions, dismissing all four of Chemicar’s challenged claims, finding that Chemicar’s allegations were insufficiently pleaded. Under the familiar Rule 12(b)(6) standard, Delaware courts: “(1) accept all well pleaded factual allegations as true, (2) accept even vague allegations as ‘well pleaded’ if they give the opposing party notice of the claim, [and] (3) draw all reasonable inferences in favor of the non-moving party.” But the court also emphasized the limiting principle: it is “not required to accept every strained interpretation” of the allegations.
The court first addressed Chemicar’s fiduciary duty claim against Penney. The complaint alleged that Penney failed to provide reports and information, steered business toward a narrow strategy, and favored a related-party vendor. But the court held that a “conclusory assertion that Penney failed to circulate certain reports—with no pled facts identifying a single instance in which Penney received an information request and refused to comply—does not support an inference of ‘reckless indifference’ ‘without the bounds of reason’” needed to plead a duty-of-care violation. Nor did Chemicar’s use of the word “leverage” turn the allegation into a loyalty claim. On the books-and-records theory, the court found that a “bare allegation” that Penney “refused” to produce records did not state a claim where the complaint did not allege a demand, compliance with 8 Del. C. § 220, or any response by Penney. In other words, the complaint described speculative concerns, but not the sort of concrete facts needed to turn those concerns into a viable fiduciary claim.
The court next addressed Chemicar’s self-dealing theory, and again found it lacking in sufficiently pleaded facts. Chemicar alleged that Penney caused Finixa USA to “prioritize” payments to third-party UYL, allegedly tied to Penney or his family, while Chemicar’s invoices went unpaid. The court first found the “prioritization” theory unsupported because Chemicar did not plead facts suggesting that Finixa USA lacked funds to pay all vendors and therefore had to favor some debts over others. Looking past the conclusory framing, the court recognized that an interested transaction may call for entire fairness review, but quoted In re Hennessy Cap. Acq. Corp. IV S’holder Litig. for the limiting factor: “Entire fairness is not . . . a free pass to trial.” 318 A.3d 306, 319 (Del. Ch. 2024), aff’d, 337 A.3d 1214 (Del. 2024). Under Monroe Cty. Empls.’ Ret. Sys. v. Carlson, a “plaintiff must make factual allegations about the transaction in the complaint that demonstrate the absence of fairness.” 2010 WL 2376890, at *2 (Del. Ch. June 7, 2010). The court found that Chemicar made only conclusory allegations as to fairness. Chemicar’s allegation that UYL was “overpaid” for “insurance and utilities” and “unwarranted services or expenses” was conclusory because the pleading did not say what UYL provided, what those goods or services were worth, what Finixa USA paid, or why the payments were excessive. Those conclusory allegations did not support a reasonable inference that Penney caused Finixa USA to enter into an unfair transaction in breach of his duty of loyalty.
Separately, Chemicar’s duty-of-care theory based on Penney’s alleged sales strategy also failed because the complaint did not plead facts supporting an inference of gross negligence. Chemicar alleged that Penney pursued an unduly narrow sales strategy, focusing on a single buying group and a limited customer base. Under Delaware law, a duty-of-care claim challenging business decisions requires allegations of gross negligence—i.e., conduct reflecting “reckless indifference” or “actions that are without the bounds of reason.” As the court observed, “the burden to plead gross negligence is a difficult one.” The court explained that Chemicar’s allegation was, at most, a disagreement about how to run the business—a matter of business judgment—and not a basis on which to infer reckless indifference. Because Chemicar did not plead facts showing why that focus was irrational, reckless, or outside the bounds of reason—rather than merely unsuccessful or disputed—the “[c]omplaint does nothing more than allege that Penney focused his managerial efforts on a specific group of customers.” Without those supporting facts, the court found that “[w]hile Chemicar may disagree with that business decision, this does not support an inference of ‘reckless indifference’ ‘without the bounds of reason’ necessary to state a claim for breach of the duty of care.” As this reasoning demonstrates, the more demanding the theory or standard, e.g., gross negligence, bad faith, or entire fairness, the more factual detail a plaintiff must marshal.
Chemicar’s aiding-and-abetting theory required pleading both an underlying fiduciary breach and knowing participation by the other venture partner. The court found that the pleadings did neither. Because the fiduciary duty claim was not adequately pleaded, the aiding-and-abetting claim lacked a viable predicate. Independently, the court held that Chemicar’s allegations of Caerus’s “assistance” were far too conclusory to support an inference of knowing participation. Nor did imputation solve the problem. As the court explained, even if knowledge may in some circumstances be imputed to an entity, the entity’s own conduct must still be pleaded with specificity. Here, the only conduct Chemicar alleged was “assistance,” and the court held that the rote allegation of assistance, without more, “does not come close” to pleading knowing participation.
The contract claims failed for a different, yet related, reason. A breach claim requires a contractual obligation, breach, and resulting harm. For Caerus, the court asked whether the Shareholders Agreement actually imposed the duty Chemicar identified and whether the pleading connected that duty to Caerus’s conduct. Section 4(B)(5) required the shareholders to cause the Board to require and demand CEO reports. The counterclaims alleged that Penney did not provide reports; they did not offer facts showing that Caerus caused the Board not to act. Section 11 gave shareholders information rights, but did not impose on Caerus an obligation to produce company records. The “policy decision” theory failed because the counterclaims alleged nonpayment to Chemicar and payment to UYL, but no facts showing a Company policy, a cash constraint requiring prioritization, or Caerus’s role in causing either. And the affiliate-approval theory failed because the pleadings did not connect the relevant agreements, timing, and affiliate definition to a duty breached by Caerus.
The court applied the same discipline to the Employment Agreement claim against Penney. Even assuming a breach, Chemicar sought only money damages and, in the court’s words, “utterly failed to plead” that Chemicar or the Company suffered cognizable harm, “much less what that harm might be.” The court’s reasoning spells out what a plaintiff needs to plead an adequate contract claim: specifically identify the provision, identify who owed the obligation, plead what that defendant did or failed to do, and identify the injury or the equitable relief that makes the claim justiciable.
Finally, the court denied Chemicar’s request for leave to amend because Chemicar had elected to stand on its pleadings rather than amend in response to the motions to dismiss, and the court found no good cause to excuse that choice. The result was dismissal with prejudice, giving the opinion added significance as a pleading-stage warning for plaintiffs considering whether to refine thin allegations before opposing dismissal on the merits.
Key Takeaways
While Chemicar is not a doctrinal shift, the opinion serves as a valuable playbook for defendants moving to dismiss. Delaware’s notice-pleading standard remains genuinely permissive, yet the opinion is a reminder that the standard “does not totally relieve a plaintiff of the burden to plead facts, not conclusions”; the more exacting the theory or standard invoked (e.g., gross negligence, entire fairness, knowing participation), the more granular those facts must be. Chemicar is a useful illustration of that boundary. Chemicar’s challenged claims did not fail because Delaware notice pleading is demanding; it lost because, at each critical point, the pleaded facts did not support the inference Chemicar asked the court to draw. Read together, the dismissed claims trace the different ways a pleading can come up short. The failure of Chemicar’s fiduciary-duty and aiding-and-abetting counts show conclusory rhetoric standing in for facts the plaintiff never supplied. The contract claims show that the deficiency might not take the form of “not enough facts” but often looks like a gap in an element the plaintiff assumed away. The decision is a useful reminder that Delaware courts will not treat that “relaxed” standard as a backdoor to sustain claims built on labels, characterizations, or speculation rather than well-pleaded factual allegations.
This post is as of the posting date stated above. Sidley Austin LLP assumes no duty to update this post or post about any subsequent developments having a bearing on this post.
